Choosing between IGF-1 LR3 and HGH comes down to your goals, experience level, budget, and risk tolerance
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers Gobburu JV, Agers H, Jusko WJ, Ynddal L Pharmaceutical Research (1999) This PK/PD study in human volunteers documented Ipamorelin's pharmacokinetic profile, showing peak GH concentrations approximately 30-40 minutes post-injection with effects lasting 2-3 hours
24 weeks (conservative cycle) 3-4 x 10 mg vials Adds 8 more weekly doses at the maintenance step
Anxiety and irritability are possible, particularly in the first few weeks
The biomechanics of adiposity structural and functional limitations of obesity and implications for movement